Argent Trust CO Halozyme Therapeutics, Inc. Transaction History

Argent Trust CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$37.81 - $52.4 $3,894 - $5,397	103 Added 1.38%	7,592 $397,000
Q1 2024 May 10, 2024	BUY	$33.68 - $41.95 $14,549 - $18,122	432 Added 6.12%	7,489 $304,000
Q4 2023 Feb 09, 2024	SELL	$33.32 - $42.1 $6,497 - $8,209	-195 Reduced 2.69%	7,057 $260,000
Q2 2023 Aug 11, 2023	BUY	$30.28 - $38.74 $219,590 - $280,942	7,252 New	7,252 $261,000
Q4 2022 Feb 10, 2023	BUY	$40.06 - $59.44 $159,719 - $236,987	3,987 New	3,987 $226,000

543

125M

294K

180K

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $6.57B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

Get notified when there are updates to the investment portfolio of Argent Trust CO, based on Form 13F filings with the SEC.

Stay updated on Argent Trust CO with notifications on news.